Andreea Scacioc1, Carla Schmidt2,3, Tommy Hofmann4, Henning Urlaub5,6, Karin Kühnel7,8, Ángel Pérez-Lara9. 1. Research Group Autophagy, Max-Planck-Institute for Biophysical Chemistry, Am Faßberg 11, 37077, Göttingen, Germany. 2. Interdisciplinary research center HALOmem, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120, Halle, Germany. carla.schmidt@biochemtech.uni-halle.de. 3. Bioanalytical Mass Spectrometry Group, Max-Planck-Institute for Biophysical Chemistry, Am Faßberg 11, 37077, Göttingen, Germany. carla.schmidt@biochemtech.uni-halle.de. 4. Interdisciplinary research center HALOmem, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120, Halle, Germany. 5. Bioanalytical Mass Spectrometry Group, Max-Planck-Institute for Biophysical Chemistry, Am Faßberg 11, 37077, Göttingen, Germany. 6. Bioanalytics Group, University Medical Center Göttingen, Robert-Koch-Strasse 40, 37075, Göttingen, Germany. 7. Research Group Autophagy, Max-Planck-Institute for Biophysical Chemistry, Am Faßberg 11, 37077, Göttingen, Germany. kkuehne@mpibpc.mpg.de. 8. Nature Communications, 4 Crinan Street, London, N1 9XW, United Kingdom. kkuehne@mpibpc.mpg.de. 9. Department of Neurobiology, Max-Planck-Institute for Biophysical Chemistry, Am Faßberg 11, 37077, Göttingen, Germany. francisco-angel.perez-lara@mpibpc.mpg.de.
Abstract
PROPPINs (β-propellers that bind polyphosphoinositides) are PtdIns3P and PtdIns(3,5)P2 binding autophagy related proteins. They contain two phosphatidylinositolphosphate (PIP) binding sites and a conserved FRRG motif is essential for PIP binding. Here we present the 2.0 Å resolution crystal structure of the PROPPIN Atg18 from Pichia angusta. We designed cysteine mutants for labelling with the fluorescence dyes to probe the distances of the mutants to the membrane. These measurements support a model for PROPPIN-membrane binding, where the PROPPIN sits in a perpendicular or slightly tilted orientation on the membrane. Stopped-flow measurements suggest that initial PROPPIN-membrane binding is driven by non-specific PIP interactions. The FRRG motif then retains the protein in the membrane by binding two PIP molecules as evident by a lower dissociation rate for Atg18 in comparison with its PIP binding deficient FTTG mutant. We demonstrate that the amine-specific cross-linker Bis(sulfosuccinimidyl)suberate (BS3), which is used for protein-protein cross-linking can also be applied for cross-linking proteins and phosphatidylethanolamine (PE). Cross-linking experiments with liposome bound Atg18 yielded several PE cross-linked peptides. We also observed intermolecular cross-linked peptides, which indicated Atg18 oligomerization. FRET-based stopped-flow measurements revealed that Atg18 rapidly oligomerizes upon membrane binding while it is mainly monomeric in solution.
PROPPINs (β-propellers that bind polyphosphoinositides) are PtdIns3P and PtdIns(3,5)P2 binding autophagy related proteins. They contain two phosphatidylinositolphosphate (PIP) binding sites and a conserved FRRG motif is essential for PIP binding. Here we present the 2.0 Å resolution crystal structure of the PROPPIN Atg18 from Pichia angusta. We designed cysteine mutants for labelling with the fluorescence dyes to probe the distances of the mutants to the membrane. These measurements support a model for PROPPIN-membrane binding, where the PROPPIN sits in a perpendicular or slightly tilted orientation on the membrane. Stopped-flow measurements suggest that initial PROPPIN-membrane binding is driven by non-specific PIP interactions. The FRRG motif then retains the protein in the membrane by binding two PIP molecules as evident by a lower dissociation rate for Atg18 in comparison with its PIP binding deficient FTTG mutant. We demonstrate that the amine-specific cross-linker Bis(sulfosuccinimidyl)suberate (BS3), which is used for protein-protein cross-linking can also be applied for cross-linking proteins and phosphatidylethanolamine (PE). Cross-linking experiments with liposome bound Atg18 yielded several PE cross-linked peptides. We also observed intermolecular cross-linked peptides, which indicated Atg18 oligomerization. FRET-based stopped-flow measurements revealed that Atg18 rapidly oligomerizes upon membrane binding while it is mainly monomeric in solution.
During macroautophagy, denoted here as autophagy, an expanding isolation membrane also called the phagophore engulfs cytoplasmic content. After fusion of the isolation membrane a double-membraned vesicle, the autophagosome is formed, which then fuses with the vacuole where its content is degraded. Autophagy is important for maintaining cellular homeostasis and is upregulated during starvation[1]. Various non-selective and selective autophagy subtypes exist. Atg18 is a core autophagy protein that belongs to the PROPPIN family (β-propellers that bind polyphosphoinositides)[2]. WIPI1 (WD-40 repeat containing protein that interacts with PtdIns)[3] and WIPI2 are the mammalianAtg18 orthologues[4]. Yeast contains two additional PROPPINs: Atg21 and Hsv2 (homologous with swollen vacuole phenotype 2). The three yeast PROPPINs are homologous but differ in their autophagic subtype specificities[5-8].PROPPINs specifically bind PtdIns3P and PtdIns(3,5)P2. Early mutagenesis studies showed that a conserved FRRG motif is essential for PIP binding of PROPPINs[7,9-12]. The Hsv2 crystal structure revealed that PROPPINs contain two PIP binding sites and fold as seven bladed β-propellers[13-15]. The two PIP binding sites are localized on the rim of the β-propeller and each FRRG arginine is part of one PIP binding site. The membrane insertion loop 6CD protrudes from the β-propeller core and is required for membrane binding in addition to the two PIP binding sites[14,16]. Phosphorylation of the membrane insertion loop modulates membrane binding of Atg18[17].PROPPIN membrane binding is also membrane curvature dependent. We previously showed that Hsv2 binds with an approx. 20 times higher affinity to small unilamellar vesicles (SUVs) containing either PtdIns3P or PtdIns(3,5)P2 than large unilamellar vesicles (LUVs), which had diameters of approx. 40 nm and 100 nm, respectively[16]. PROPPINs were proposed to bind perpendicular to the membrane through their two PIP binding sites on the rim and the membrane insertion loop 6CD[13-16].PIP binding is essential for in vivo PROPPIN function. Atg18 localizes in a PtdIns3P dependent manner to the preautophagosomal structure (PAS), the site where autophagosome formation is initiated[10,18]. Atg18 interacts with Atg2 at the PAS and complex formation is required for autophagosome formation[19,20]. The mammalianAtg18 orthologue WIPI2b binds Atg16L1 and recruits the Atg12-Atg5-Atg16L1 complex during autophagosomal membrane biogenesis[21]. The three yeast PROPPINs also bind PtdIns3P-dependent to endosomes, however their functions there are still unknown[22]. PtdIns(3,5)P2 binding of Atg18 mediates its localization to the vacuole[9]. Atg18 has a regulatory role as part of the Fab1-containing PtdIns3P 5-kinase complex at the vacuole[23,24]. Yeastatg18Δ cells have enlarged vacuoles[9,23] and mutagenesis studies showed that both Atg18PIP binding sites are important for maintaining vacuolar homeostasis[13].We set out to gain further insights into the mechanism of PROPPIN-membrane binding. Here we worked with recombinant expressed Pichia angusta (Hansenula polymorpha) Atg18 because S. cerevisiaeAtg18 is not soluble when expressed in E. coli
[25]. Pichia angusta (Pa) and Pichia pastoris (Pp) are methylotrophic yeasts. PaAtg18 and PpAtg18 share 60% sequence identity. PpAtg18 was previously characterised in vivo and is required for autophagy and pexophagy[6]. We crystallised PaAtg18 and determined its structure at 2.0 Å resolution. Based on this structure we designed mutants to probe the distances of selected Atg18 residues to the membrane to experimentally test the proposed model for PROPPIN-membrane binding. We used stopped-flow measurements to study the influence of the FRRG motif on the kinetics of PROPPIN-membrane binding. Furthermore, we performed liposome-Atg18 cross-linking experiments and detected several peptide-lipid cross-links by mass spectrometry. We also identified several intermolecular cross-linked Atg18 peptides indicating Atg18-Atg18 interactions. Native mass spectrometry confirmed the formation of Atg18 oligomers. We further investigated these findings employing FRET based stopped-flow measurements, which showed that Atg18 rapidly oligomerizes upon membrane binding.
Results
Pichia angusta Atg18 structure
Well-diffracting Pichia angusta Atg18 crystals (denoted as Atg18 hereafter) were obtained through in situ proteolysis crystallization with proteinase K. The 2.0 Å resolution structure was determined by molecular replacement and contains two molecules in the P1 unit cell (Table 1, Supplementary Figure 2). Atg18 folds as a seven bladed β-propeller with a non-velcro propeller closure topology as previously observed for the Hsv2 homologs[13-15] (Fig. 1A). The Atg18 and Kluyveromyces lactis (K. lactis) Hsv2 structures (PDB accession code: 4AV9) superimpose with an r.m.s.d. of 1.5 Å and share 24.8% sequence identity (Supplementary Figure 1). The innermost β-strands of the blades are denoted as A and the outer strands as D. Strands 7A and 7B are larger than the other strands of the β-propeller and protrude, however this area is not well conserved among the Atg18 orthologues (Fig. 1A,D). The membrane insertion loop 6CD comprising residues 297–437 is missing from the model (Fig. 1A).
Table 1
Data collection and refinement statistics.
Space group
citrate bound Atg18
phosphate bound Atg18
P1
P1
cell dimensions
a, b, c (Å)
57.8, 58.0, 62.2
58.2, 58.3, 62.3
α, β, γ (°)
84.2, 81.2, 87.0
83.7, 80.9, 86.8
resolution (highest res. shell) (Å)
41.3–2.0 (2.1–2.0)
45.5–2.5 (2.7–2.5)
Rfactor (%)
5.7 (36.1)
13.3 (64.5)
wavelength (Å)
1.000
0.979
no. of observed reflections/unique reflections
102367/51797
200927/27376
I/σ (I)
9.6 (2.2)
12.8 (3.4)
completeness (%)
94.5 (86.3)
98.3 (96.5)
Wilson B factor (Å2)
32.1
41.2
Refinement
molecules per unit cell
2
2
Rwork/Rfree (%)
21.4/26.9
22.1/26.5
residues included in model
A: 32–179, 201–296, 438–467, 485–524
A:33–179, 201–297, 438–467, 484–424
B: 32–180, 201–297, 438–467, 484–525
B: 33–179, 201–297, 438–467, 485–525
number of protein atoms
4835
4751
number of ligand atoms
36
24
number of water molecules
385
119
B-factors (Å2) overall
29.0
39.4
protein
28.5
39.4
ligand
42.3
49.2
water
33.7
35.0
r.m.s.d.
bond lengths (Å)
0.010
0.003
bond angles (°)
1.20
0.65
Ramachandran favored/allowed/outliers (%)
97.4/2.4/0.2
96.6/3.4/0
Figure 1
Pichia angusta Atg18 structure. (A) Cartoon representations of Atg18 rainbow-colored from blue at the N-terminus to red at the C-terminus. The ligands and FRRG arginine side chains are shown as ball and sticks. Loop 6CD (297–437) is missing and marked through the last ordered residues 296 and 438. Panels (A–C) show the protein in the same orientation. Surface representations of Atg18 showing (B) surface charges with blue depicting positive and red negative charges and (C) conservation of the molecule. Conservation analysis was done with Consurf[46]. Proteins used for the sequence alignment are listed in the Methods section. (D) Close up on site 1 with bound citrate. The omit mFo-DFc difference map, where m is the figure of merit and D the sigma A weighting factor has a contour level of σ = +2.5. Scheme showing ligand protein interactions was adapted from LigPlot+. Hydrogen bonds and salt bridges between ligand and protein are shown with dashed lines and distances are given in Ångstrom. Water molecules are depicted as cyan spheres. (E) Site 1 with a bound phosphate ion. The 2.5 Å resolution 2mFo-DFc map is contoured at 1.0 σ. (F) PIP binding site 2 with a bound phosphate ion. The 2.0 Å resolution 2mFo-DFc electron density map is contoured at 1.0 σ. Residues with disordered side chains are marked with an asterisk.
Data collection and refinement statistics.Pichia angustaAtg18 structure. (A) Cartoon representations of Atg18 rainbow-colored from blue at the N-terminus to red at the C-terminus. The ligands and FRRG arginine side chains are shown as ball and sticks. Loop 6CD (297–437) is missing and marked through the last ordered residues 296 and 438. Panels (A–C) show the protein in the same orientation. Surface representations of Atg18 showing (B) surface charges with blue depicting positive and red negative charges and (C) conservation of the molecule. Conservation analysis was done with Consurf[46]. Proteins used for the sequence alignment are listed in the Methods section. (D) Close up on site 1 with bound citrate. The omit mFo-DFc difference map, where m is the figure of merit and D the sigma A weighting factor has a contour level of σ = +2.5. Scheme showing ligand protein interactions was adapted from LigPlot+. Hydrogen bonds and salt bridges between ligand and protein are shown with dashed lines and distances are given in Ångstrom. Water molecules are depicted as cyan spheres. (E) Site 1 with a bound phosphate ion. The 2.5 Å resolution 2mFo-DFc map is contoured at 1.0 σ. (F) PIP binding site 2 with a bound phosphate ion. The 2.0 Å resolution 2mFo-DFc electron density map is contoured at 1.0 σ. Residues with disordered side chains are marked with an asterisk.The conserved FRRG motif is localized on strand 5D and the loop connecting it with strand 6A. The FRRG F261 on strand 5D forms an off-centre parallel stacking interaction with F294 on strand 6C stabilizes the β-propeller fold and is not involved in membrane binding. The glycine in the motif is a requirement for steric reasons. The two FRRG arginines point into different directions, R262 is oriented towards PIP binding site 1 and R263 is part of PIP binding site 2 (Fig. 1A). Site 1 contains a citrate molecule and site 2 binds a phosphate ion both originating from the crystallization buffer.When Atg18 crystals were transferred to a 0.4 M sodium dihydrogen phosphate containing cryoprotectant lacking citrate the citrate ion bound in site 1 was replaced by a phosphate. The structure with phosphate ions bound to both PIP binding sites was determined at 2.5 Å resolution (Table 1, Fig. 1E). In both phosphate and citrate site 1 structures salt bridges are formed between the conserved residues R248 and H221 and either the phosphate or carboxylate groups, respectively (Fig. 1D,E). Furthermore, both ligands form hydrogen bonds with S241 and the amidenitrogen of R222. When comparing the positions of the two ligands towards each other, the phosphate ion sits between the middle carboxylate group of the citrate and the carboxylate forming a hydrogen bond with S241.The phosphate ion bound in site 2 extensively interacts with the protein. It forms salt bridges with H292 and FRRG R263 and hydrogen bonds with T288 and T290 (Fig. 1F). The two PIP binding sites are positively charged and part of a highly conserved region on the rim of the propeller comprising blades four, five and six (Fig. 1B, C). The region including loops 2AB and 2CD, which are localized opposite of the two PIP binding sites, is also highly conserved among the Atg18 orthologues pointing towards a functional role for this region, for example in protein-protein interactions (Fig. 1C, left panel). Indeed, mutagenesis studies with S. cerevisiaeAtg18 showed that loop regions 2AB and 2BC are important for Atg2-Atg18 complex formation[15].
Comparison of Atg18 and Atg18 FTTG membrane binding kinetics
The conserved FRRG motif is essential for membrane binding of PROPPINs[7,9,10]. A mutation of the FRRG motif to FTTG abolishes PIP binding of PROPPINs[9-11,19]. We analyzed the kinetics of Atg18 and Atg18 FTTG membrane binding with stopped-flow measurements. The single cysteine mutants S448C and S448C with FTTG were used for site-directed labelling with the FRET donor dye Alexa Fluor 488. S448 is located in the loop connecting strands 6D and 7A near PIP binding site 2.Measurements were done with large unilamellar vesicles (LUVs) containing 1% PtdIns(3,5)P2, which were labelled with the FRET acceptor dye Texas Red. These LUVs consisted of dioleoylphosphatidylcholine (DOPC)/dioleoylphosphatidylethanolamine (DOPE)/Texas Red-PE/PtdIns(3,5)P2 (79:18:2:1, molar ratio) and had diameters in the range of 120–140 nm (Supplementary Figure 3). The observed fluorescence increase is only due to FRET between the Alexa Fluor 488 and the labelled vesicles because no light scattering was observed at this protein concentration and the highest LUV concentration used in these measurements (Supplementary Figure 4).The much lower FRET intensity of S448C FTTG indicates much weaker binding to liposomes in comparison with S448CAtg18 (Fig. 2A,B,D). The weak FRET signal observed for S448C FTTG makes accurate rate determination difficult and results in a higher standard error. However, no significant difference was observed in the association rate (k
on) of both proteins, whereas the apparent dissociation rate (k
off,app) was higher for the FTTG mutant (Table 2 and Fig. 2C) taking into account the experimental uncertainties (standard errors).
Figure 2
Stopped-flow measurements with S448C Atg18 and S448C FTTG Atg18. Time courses of Texas Red (A and B) or Rhodamine B (E and F) fluorescence emission measurements at different accessible lipid concentrations are shown for S448C Atg18 (A and E) and S448C FTTG Atg18 (B and F). A scale-up of the the traces in Fig. 2B and fitting results are shown in Supplementary Figure 11 and Supplementary Tables 3–7, respectively. (C and G) Graphs showing the dependency of k
obs1 from the accessible lipid concentration. The y-intercept provides the dissociation rate constant k
off, and the slope yields the association rate constant k
on. Bars represent the standard errors of three to five technical repeats. The solid line shows a weighted linear fit (equation 2 in Methods). Amplitudes of the k
obs1 used for data analysis are shown in Supplementary Figure 5. (D and H) Increases of Texas Red (D) or Rhodamine B (H) fluorescence emission are shown at different accessible lipid concentrations for S448C Atg18 and S448C FTTG Atg18.
Table 2
Atg18 kinetic measurements.
Alexa Fluor 488-Texas Red
Alexa Fluor 488-Rhodamine B
kon (mM−1*s−1)
koff,app (s−1)
kon (mM−1*s−1)
koff,app (s−1)
S448C
0.85 ± 0.22
0.66 ± 0.04
0.57 ± 0.38
0.19 ± 0.01
S448C FTTG
1.55 ± 0.39
1.03 ± 0.06
0.93 ± 0.20
0.36 ± 0.03
Rate constants for the kinetics of Atg18 binding calculated from data shown in Fig. 2C and F. The errors represent the standard error obtained from linear fitting.
Stopped-flow measurements with S448CAtg18 and S448C FTTG Atg18. Time courses of Texas Red (A and B) or Rhodamine B (E and F) fluorescence emission measurements at different accessible lipid concentrations are shown for S448CAtg18 (A and E) and S448C FTTG Atg18 (B and F). A scale-up of the the traces in Fig. 2B and fitting results are shown in Supplementary Figure 11 and Supplementary Tables 3–7, respectively. (C and G) Graphs showing the dependency of k
obs1 from the accessible lipid concentration. The y-intercept provides the dissociation rate constant k
off, and the slope yields the association rate constant k
on. Bars represent the standard errors of three to five technical repeats. The solid line shows a weighted linear fit (equation 2 in Methods). Amplitudes of the k
obs1 used for data analysis are shown in Supplementary Figure 5. (D and H) Increases of Texas Red (D) or Rhodamine B (H) fluorescence emission are shown at different accessible lipid concentrations for S448CAtg18 and S448C FTTG Atg18.Atg18 kinetic measurements.Rate constants for the kinetics of Atg18 binding calculated from data shown in Fig. 2C and F. The errors represent the standard error obtained from linear fitting.We repeated the kinetic measurements with Lissamine Rhodamine B-PE instead of Texas Red-PE as the labelled lipid to further support our findings. Lissamine Rhodamine B-PE has a higher spectral overlap with Alexa Fluor 488 than Texas Red-PE, which allowed us to perform measurements at lower concentrations with a reliable signal/noise ratio. The final protein concentration was decreased from 0.25 µM to 0.125 µM in order to reduce aggregation during measurements (see below). Similar results were obtained under theses condition compared with the Texas Red-PE experiments, i.e. no significant difference in the association rates (k
on) but a higher apparent dissociation rate (k
off,app) was observed for the FTTG mutant in comparison with the S448C mutant (Table 2 and Fig. 2 E,F,G,H). These data demonstrate that initial membrane recruitment of PROPPINs is not mediated by PIP binding to the two PIP binding sites, suggesting non-specific electrostatic interactions with PIP molecules and negatively charged phospholipids mediate the membrane recruitment of PROPPINs.
Analysis of membrane-protein distances with a fluorescence based liposome binding assay
In a previous study, we proposed a model for PROPPIN-membrane interactions, where the protein sits perpendicular on the membrane and binds through its two PIP binding sites on the rim of the β-propeller[13]. Here we set up two different fluorescence based liposome binding assays to probe the distances of selected residues towards the membrane in order to validate this model.We prepared eight single-site cysteine mutants (Fig. 3A). Membrane binding of the mutants was confirmed through liposome flotation assays with LUVs containing 1% PtdIns(3,5)P2 (Fig. 3B, Supplementary Figure 7). In contrast, the S448C FTTG Atg18 mutant did not bind to liposomes, showing that protein-membrane binding is PIP specific. We measured the circular dichroism spectra of the mutants which confirmed their correct folding (Supplementary Figure 6).
Figure 3
(A) Atg18 structure showing residues, which were mutated to cysteines for fluorescence labeling experiments. E170 is marked with an asterisk because its side chain is disordered in the structure and was modelled as an alanine. (B) Liposome flotation assays were performed with wild-type, cysteine-free and single cysteine Atg18 mutants using 100 nm LUVs composed of DOPC/DOPE/Texas Red-PE/PtdIns(3,5)P2 (76:21:2:1, molar ratio). The top two fractions of the gradient show protein bound to liposomes and bottom fractions contain unbound protein. The S448C FTTG mutant served as a negative control. (C) Observed changes of the normalized fluorescence at 520 nm for the Oregon Green labelled mutants after Texas Red liposome addition. (D) Model for Atg18 binding at the membrane. The docking was manually performed taking data from (C) into account. Residues are color coded according to the observed change in normalized fluorescence. Color bar is shown.
(A) Atg18 structure showing residues, which were mutated to cysteines for fluorescence labeling experiments. E170 is marked with an asterisk because its side chain is disordered in the structure and was modelled as an alanine. (B) Liposome flotation assays were performed with wild-type, cysteine-free and single cysteineAtg18 mutants using 100 nm LUVs composed of DOPC/DOPE/Texas Red-PE/PtdIns(3,5)P2 (76:21:2:1, molar ratio). The top two fractions of the gradient show protein bound to liposomes and bottom fractions contain unbound protein. The S448C FTTG mutant served as a negative control. (C) Observed changes of the normalized fluorescence at 520 nm for the Oregon Green labelled mutants after Texas Red liposome addition. (D) Model for Atg18 binding at the membrane. The docking was manually performed taking data from (C) into account. Residues are color coded according to the observed change in normalized fluorescence. Color bar is shown.First, cysteine residues were labelled with the environment sensitive dye 6-bromoacetyl-2-dimethylaminonaphthalene (BADAN). Fluorescence emission of BADAN is quenched in solution, however when the dye is in contact with a membrane its emission increases. BADAN-labelled proteins were incubated with LUVs containing 1% PtdIns(3,5)P2 for 10 min before acquisition of the fluorescence spectra. Proteins were mixed with the same buffer volume to obtain the fluorescence spectra in solution (Supplementary Figure 8). A large increase in fluorescence intensity upon addition of liposomes was observed for the S448C and S459C mutants. Both residues are close to PIP binding site 2. The I256C mutant in proximity of PIP binding site 1 showed no significant increase in fluorescence emission. One possible explanation is that this residue might not be inserted into the membrane and might instead be located at the membrane-aqueous interface. Of notice, the usage of the BADAN dye has several disadvantages, which includes a high unspecific labelling and different fluorescence intensities due to different local protein enviroments. To overcome these potential problems, we used a second complementary approach and performed FRET measurements with Oregon Green labelled protein and Texas Red labelled vesicles. The Oregon Green fluorescence in the presence of liposomes was monitored (Supplementary Figure 9). When the Oregon Green dye gets in proximity of the Texas Red labelled vesicles its fluorescence decreases. We observed the highest decrease in donor fluorescence for S448C, which is consistent with the BADAN measurements and also for I256C and S157C mutants, suggesting that these residues are closer to the membrane (Fig. 3C). Unexpectedly, a significant decrease was also observed for S51C and H94C mutants, suggesting that these residues are also in proximity of the membrane. Based on these FRET measurements we propose a manually docked model, where Atg18 binds the membrane perpendicular or slightly tilted, in contrast to an orientation where the β-propeller would lay planar on the membrane (Fig. 3D).
Atg18 protein and liposome interactions analyzed by chemical cross-linking and mass spectrometry
To further characterize membrane binding of Atg18 we designed a chemical cross-linking strategy employing Bis(sulfosuccinimidyl)suberate (BS3). Samples were digested with trypsin and cross-linked di-peptides were then enriched by size-exclusion chromatography. We used a high-sensitivity, high-resolution mass spectrometer (Orbitrap Fusion Tribrid Mass Spectrometer) for liquid chromatography-coupled tandem mass spectrometry (LC-MS/MS) (see Methods for details). Potential cross-links were identified by database searching using the pLink software[26].We verified unique cross-links corresponding to 101 protein interactions by evaluation of the tandem mass spectra (Supplementary Table 1). The intramolecular Atg18 cross-links are mainly located in loop regions missing in the Atg18 crystal structure suggesting flexibility of these regions (Fig. 4A). Interestingly, eight of the verified cross-linked di-peptides contained the same or overlapping peptide sequences showing that they derived from intermolecular cross-linking of two Atg18 molecules (Fig. 4B).
Figure 4
(A) Intramolecular cross-links of Atg18 are shown with red lines. Cross-links that are not included in the crystal structure are indicated by dotted lines. The seven blades of the β-propeller are rainbow colored. Residues missing from the crystal structure are highlighted in grey and light orange (residues 297–437, blade 6). (B) Bar diagramme indicating intermolecular Atg18 interactions (blue Lines). (C) Native mass spectrum of Atg18 oligomers. Calculated masses of the oligomers are given. (D) Intramolecular cross-links identified in Atg18 in the presence of liposomes. (E) Blue lines indicate intermolecular cross-links between two Atg18 molecules in the presence of liposomes. Red lines show protein-PE cross-links. PE cross-linked residues are labelled.
(A) Intramolecular cross-links of Atg18 are shown with red lines. Cross-links that are not included in the crystal structure are indicated by dotted lines. The seven blades of the β-propeller are rainbow colored. Residues missing from the crystal structure are highlighted in grey and light orange (residues 297–437, blade 6). (B) Bar diagramme indicating intermolecular Atg18 interactions (blue Lines). (C) Native mass spectrum of Atg18 oligomers. Calculated masses of the oligomers are given. (D) Intramolecular cross-links identified in Atg18 in the presence of liposomes. (E) Blue lines indicate intermolecular cross-links between two Atg18 molecules in the presence of liposomes. Red lines show protein-PE cross-links. PE cross-linked residues are labelled.To gain further insights into possible oligomerisation of Atg18 we studied its intact assemblies by native mass spectrometry[27]. For this we employed a Q-ToF mass spectrometer modified for transmission of high-mass complexes[28]. Indeed, mass spectra of Atg18 reveal oligomers up to tetramers (Fig. 4C). Of these, monomeric Atg18 is most abundant, however, dimer, trimer and tetramer were obtained at reasonable intensities (50%, 20% and 10%, respectively).We then incubated a mixture of Atg18 and LUVs composed of DOPC/DOPE/PtdIns(3,5)P2 (75:23:2, molar ratio) with BS3 following the same protocol as described above (Fig. 4A). In order to identify protein-lipid adducts, we performed a dependent database search allowing for unknown protein modifications (see Methods for details). The theoretical mass of a lipid adduct was calculated as follows: DOPE accounts for 743.36 Da and the BS3-linker for 140.074 Da; subtraction of two protons, which are released from the lipid and peptide amine groups during covalent linkage yields a mass adduct of 881.42 Da for a DOPE cross-linked peptide. Indeed, we identified several peptides with a mass adduct of 881.40 Da employing the MaxQuant software[29]. We assessed these potential hits by their peptide and modification site probability scores and thus approved four peptide sequences and nine cross-linked sites (Supplementary Table 2). Interestingly, in addition to cross-linked lysine residues we also identified several cross-linked serine, theronine and tyrosine residues (Fig. 4B). Cross-linking of these amino acids with BS3 was previously reported for peptides and proteins[30].The observed lipid-binding sites T268 and K269 are in proximity of the FRRG motif (residues 261–264) (Fig. 4E). K390 is localized in the membrane insertion loop 6CD, which is missing in the crystal structure. K472 localized in the disordered loop 7AB, which is nearby PIP binding site 2. Five cross-linked residues are present in the N-terminal region of Atg18 (S-2, S3, S21, Y22 and K27). The first 31 residues of Atg18 are disordered in the crystal structure and their flexibility allows interactions with the liposome membrane. Indeed, a different cross-linking pattern was observed for the N-terminal region of Atg18 either in the presence (Fig. 4D) or absence of liposomes (Fig. 4A). Various interactions that are formed in the absence of liposomes were not identified in the presence of lipids. In addition cross-links in close proximity to protein-lipid interactions (see above) were identified suggesting that the flexible N-terminal part of Atg18 interacts with the membrane.We also identified 49 protein interactions within Atg18 and seven interactions specific for Atg18-Atg18 oligomers in the Atg18-liposome cross-linking experiments, which were also observed for BS3 cross-linking of Atg18 alone (Supplementary Table 1). The seven lysine residues, which formed intermolecular cross-links are K102 on strand 2C, K107 in loop 2CD and the disordered residues K181 in loop 4BC and residues K390, K392 and K429 in loop 6CD and one lysine in the N-terminal His-tag. Both, the detected intramolecular cross-links and the observation that Atg18 oligomers up to tetramers were measured in native mass spectrometry measurements show that Atg18 oligomerizes.
Analysis of Atg18-Atg18 interactions through FRET based stopped-flow measurements
We performed FRET based stopped-flow measurements to further characterize Atg18-oligomerization. The protein was labelled with FRET dye pairs for these experiments. This set-up allowed us to study Atg18-Atg18 interactions either free in solution, in the presence of Ins(1,3,5)P3, which is the PtdIns(3,5)P2 head group, or with liposomes. We selected the C113 mutant for labelling, because this cysteine is nearby residues K102 and K107, which formed intermolecular cross-links.The Atg18 C113 mutant was either labelled with the FRET donorAlexa Fluor 488 or the acceptor dye Alexa Fluor 546. A very weak FRET signal was observed when measurements were done with the two labelled proteins in solution (Fig. 5A and Supplementary Figure 10B). However, measurements with C113-Alexa Fluor 546 labelled Atg18 bound to LUVs composed of DOPC/DOPE/Texas Red-PE/PtdIns(3,5)P2 (79:18:2:1, molar ratio) and C113-Alexa Fluor 488 labelled Atg18 free in solution yielded a strong FRET signal. In contrast, only a very weak FRET signal was observed for the two labelled proteins free in solution when Ins(1,3,5)P3 was present.
Figure 5
Characterization of Atg18-Atg18 interactions with FRET based stopped-flow measurements. (A) Graph shows time courses of rapid mixing of 0.5 µM Atg18 C113 (labelled with Alexa Fluor 488) with 0.5 µM Atg18 C113 (labelled with Alexa Fluor 546) either in the presence of unlabeled liposomes (1 mM total lipid), Ins(1,3,5)P3 (6 µM) or free in solution. (B) Experiments are similar to (A), but Oregon Green and Texas Red were used as donor and acceptor dyes instead. (C) Measurements with Texas Red labelled liposomes in comparison with measurements using labelled proteins for monitoring of the FRET signal. Unlabelled protein was mixed with unlabelled protein bound liposomes to monitor aggregation by measuring of the absorbance at 405 nm. Time course traces were normalized for comparison.
Characterization of Atg18-Atg18 interactions with FRET based stopped-flow measurements. (A) Graph shows time courses of rapid mixing of 0.5 µM Atg18 C113 (labelled with Alexa Fluor 488) with 0.5 µM Atg18 C113 (labelled with Alexa Fluor 546) either in the presence of unlabeled liposomes (1 mM total lipid), Ins(1,3,5)P3 (6 µM) or free in solution. (B) Experiments are similar to (A), but Oregon Green and Texas Red were used as donor and acceptor dyes instead. (C) Measurements with Texas Red labelled liposomes in comparison with measurements using labelled proteins for monitoring of the FRET signal. Unlabelled protein was mixed with unlabelled protein bound liposomes to monitor aggregation by measuring of the absorbance at 405 nm. Time course traces were normalized for comparison.Stopped-flow measurements were repeated with another FRET dye pair. Here, the C113 mutant was labelled with either Oregon Green or Texas Red. Measurements were done as described above for the Alexa Fluor labelled proteins and gave consistent results (Fig. 5B). These data show that Atg18 oligomerizes when it is membrane bound. In contrast, the protein oligomerizes only to a small degree when free in solution and the Ins(1,3,5)P3 head group is not sufficient to mediate oligomerization. We cannot distinguish between dimerization and higher order oligomerization with these experiments.In a control experiment aggregation of liposomes was monitored by injecting unlabelled proteins and liposomes and measuring the absorbance at 405 nm (Fig. 5C). Liposomes aggregate, however this process is slow in comparison to protein oligomerization. We also performed measurements with Texas Red labelled liposomes and Oregon Green labelled Atg18. The FRET signal evolves as rapidly as for the second measurement with Oregon labelled Atg18 and Texas Red labelled Atg18 bound to liposomes (Fig. 5C). These two experiments show that Atg18 oligomerization occurs very rapidly upon membrane binding of the protein.
Discussion
We determined the 2.0 Å resolution crystal structure of Pichia angustaAtg18 with a citrate molecule bound in PIP binding site 1. The citrate interacts extensively with the protein (Fig. 1D). Earlier mutagenesis work showed that residues S241 and R248 which participate in citrate binding are essential for membrane binding of S. cerevisiaeAtg18, i.e. the corresponding ScAtg18 residues are S264 and R271, respectively[13]. Bound citrates were also observed in PIP binding sites of other proteins such as the C-terminal PtdIns(3,4)P2 binding pleckstrin homology (PH) domain of humantandem PH-domain-containing protein 1 (TAPP1)[31]. Another example is the PtdIns3P binding FYVE domain from Drosophila melanogasterhepatocyte growth factor-regulated tyrosine kinase substrate (Hrs)[32]. The middle carboxylate group of the citrate bound Hrs structure (PDB: 1DVP) is near phosphate 3 in the Ins(1,3)P2 complexed humanHrs structure (PDB: 4AVX). In our Atg18 structures the middle carboxylate group is near the bound phosphate ion in site 1.The phosphate ions in site 1 and 2 of the phosphate bound Atg18 structure are located at the same positions as the sulfate ions in K. lactisHsv2 highlighting the strong conservation of the PIP binding sites[13,14]. While the overall structures of KlHsv2 and Atg18 are very similar, they vary in some of their loop regions and there are differences in the lengths of the strands in blade 7 (Supplementary Figure 1). There is an additional conserved region opposite of the PIP binding sites in Atg18, which includes loops 2AB and 2CD. Loop 2AB is involved in Atg2 binding as shown in mutagenesis studies with S. cerevisiaeAtg18[15]. In contrast, the region comprising loops 1AB and 2AB is conserved in KlHsv2. These differences in surface conservation might be of functional importance, i.e. these sites might be involved in different protein-protein interations. Atg18 and Hsv2 differ in their autophagic functions. Atg18 is a core autophagy protein that is also required for various autophagic subtypes including the cytoplasm to vacuole targeting pathway and piecemeal microautophagy of the nucleus (PMN)[5,6,10]. In contrast, Hsv2 is only needed for PMN[8].We studied the influence of the FRRG motif on PROPPIN membrane binding kinetics by comparing the binding of Atg18 and its FTTG mutant to LUVs containing PtdIns(3,5)P2 with stopped-flow measurements. We used two different FRET dye pairs for these measurements (Fig. 2). We observed for both dye pairs that Atg18 and its FTTG mutant bind with similar association rates and that the FTTG mutant has a higher apparent dissociation rate. However, the absolute rate values should be interpreted with caution because Atg18 oligomerization might result in different equilibria which could affect with the final rate values obtained for the different protein concentrations. Both Atg18 oligomerization and aggregation affect the dissociation rate determination in our experimental set-up. If binding occurs in a two-step process, when omitting aggregation, then k
off,app in equation 2 (see Methods) can be defined as k
off,app = k
off + k
oli + k
dis, where k
off is the dissociation rate of the binding step, k
oli is the rate of oligomerization and k
dis is the rate for oligomer disassembly. Here, the increase of k
off,app can be due to an increase of k
off or the two steps involved in oligomerization. When the first step of the process reaches equilibrium faster than the second one, as it is the case for diffusion-controlled process like membrane-binding processes then k
off,app ≈ k
off and k
obs1 = k
on[total accessible lipid] + k
off. Furthermore, if k
oli + k
dis ≫ k
on[total accessible lipid] or k
off, then k
obs1 is given by k
oli + k
dis and will not increase linearly with the concentration of the total accessible lipid[33]. However, the complexity of the binding process (binding and oligomerization) and the presence of early aggregation (Fig. 5C) adds uncertainty to determination of the real rates and must be interpreted with caution as stated above. Despite of this fact, our data are consistent with a mechanism for PROPPIN membrane binding kinetics, where initial membrane binding is driven by non-specific electrostatic interactions and once the PROPPIN is bound it is retained at the membrane by PIP binding of its two PIP binding sites.Based on the crystal structure we designed mutants to further characterize Atg18-membrane binding by combining fluorescence based biophysical methods and mass spectrometry. We probed the distances of selected residues towards the membrane by firstly labelling cysteines with the environment-sensitive BADAN dye and secondly through FRET measurements with Oregon Green labelled Atg18 and Texas Red labelled vesicles. We observed an increase of BADAN fluorescence upon liposome binding for the labelled mutants S448C and S459C, which are near PIP binding site 2. Our FRET experiments showed the highest decrease in donor fluorescence and thus membrane binding for S448C, which is consistent with the BADAN measurements and additionally the S157C and I256C mutants, which are in proximity of both PIP binding sites. The observed differences between both independent measurements can be explained that BADAN is an environment-sensitive dye and Atg18 oligomerization could affect the local environment of BADAN similar to a vesicle membrane. Therefore, the results of the FRET measurements are more reliable, because here direct interactions between fluorophores are monitored, thus overcoming the potential problem of Atg18 oligomerization for the BADAN measurements. Our results are consistent with a perpendicular, or slightly tilted, binding of PROPPINs towards the membrane (Fig. 3D), confirming the earlier proposed model for PROPPIN-membrane binding[13-16].With a new approach we demonstrated that the amine-specific cross-linker BS3, which is commonly used for protein-protein cross-linking[34,35] can also be used for protein-lipid cross-linking. We performed cross-linking experiments with Atg18 bound to LUVs containing PtdIns(3,5)P2 and detected DOPE-cross-linked lysine, serine, threonine and tyrosine peptides. Two residues, T268 and K269 are close to the FRRG motif. K390 is part of the membrane insertion loop 6CD.We also identified several intermolecular cross-linked peptides in our mass spectrometry analyses, which pointed towards an oligomerization of Atg18. We performed stopped-flow measurements to further investigate this finding. The stopped-flow measurements show that Atg18 oligomerizes upon membrane binding while the protein is mainly monomeric free in solution (Fig. 6). Atg18 oligomerization was also observed by cross-linking and native mass spectrometry of Atg18 in the absence of liposomes. The observed intensities of intact Atg18 oligomers in the native mass spectrometry measurements suggest an additive oligomerization mechanism and oligomerization is likely enhanced upon membrane binding as shown by stopped-flow measurements. A quantitative description of the two cross-linking experiments, in the presence and absence of LUVs, is not possible for two reasons. First, the cross-linking of Atg18 alone were performed with higher amounts of protein while the liposome binding experiments required lower protein concentrations, and second, we showed that BS3 cross-linker reacts with DOPElipids in liposomes, which will also cause quenching of the cross-linking reaction (by two DOPE molecules cross-linking with each other) and a quantitative comparison is therefore not possible.
Figure 6
Model for Atg18 membrane binding. The protein oligomerizes upon membrane binding while it is mainly monomeric in solution. Higher order oligomers might be formed by membrane bound Atg18.
Model for Atg18 membrane binding. The protein oligomerizes upon membrane binding while it is mainly monomeric in solution. Higher order oligomers might be formed by membrane bound Atg18.Oligomer formation occurs rapidly after membrane binding as identified by stopped-flow measurements and Atg18 bound liposomes aggregate later (Fig. 5C and Supplementary Figure 10A). In contrast, the protein oligomerizes only to a small extent in solution and the Ins(1,3,5)P3 head group is not sufficient to drive oligomerization (Fig. 5A,B and Supplementary Figure 10B).The seven bladed β-propeller fold is rigid and therefore membrane binding will not induce large conformational changes of the protein. Membrane bound Atg18 molecules are arranged in the same perpendicular orientation through their two PIP binding sites on the rim of the β-propeller and membrane insertion of loop 6CD. Membrane binding leads to a large local concentration increase of the protein in comparison to an aqueous environment. Movement of the protein in the lipid bilayer is restricted to lateral diffusion. Taken together these three factors, i.e. protein concentration increase upon membrane binding, lateral diffusion and parallel orientation of membrane bound Atg18 molecules will promote protein oligomerization.We cannot distinguish, whether Atg18 forms dimers or larger oligomers with the stopped-flow measurements. However, our native mass spectrometry results point towards an oligomerization beyond dimer formation because also trimers and tetramers were observed. In the cross-linking experiments two lysines, which are localized on opposite sites of the β-propeller, i.e. K102 on loop 2CD and K181 on loop 4BC formed intermolecular cross-links. K102 and K181 are localized in conserved regions of Atg18. These two observed intermolecular cross-links are compatible with a parallel side-to-side orientation of Atg18 oligomers, where neighboring molecules interact through their propeller rims (Fig. 6).Membrane curvature has also an effect on PROPPIN binding. We previously showed that Hsv2 binds with an approx. 20 times higher affinity to SUVs containing PIPs than LUVs with the same composition[16]. Our results that membrane bound Atg18 oligomerizes and that membrane curvature promotes PROPPIN membrane binding explain the in vivo observation, that Atg18 localizes to the strongly bent edge of the isolation membrane in S. cerevisiae
[36].To conclude, our results presented here give further insights into the mechanism of Atg18 membrane binding. Atg18 is initially targeted to the membrane by non-specific PIP interactions and the FRRG motif is then important for retaining the protein at the membrane. Atg18 rapidly oligomerizes upon membrane binding and likely forms larger oligomers.
Methods
Protein expression and purification
A synthetic gene encoding Pichia angustaAtg18 (UniProt entry Q5QA94) cloned in the pET-28a vector was used for expression as described previously[16]. For the cysteine-free Atg18 mutant residues C45, C59, C65, C113 and C515 were mutated to alanines with the QuikChange Lightning Multi Site-Directed Mutagenesis Kit (Agilent Technologies). The S51C, H94C, C113, S157C, E170C, I256C, S459C and S448C single cysteineAtg18 mutants were prepared. Residues R262 and R263 were changed to threonines to generate the S448C FTTG single cysteine mutant. N-terminal His-tagged wild-type and mutant proteins were purified with a 1 mL HisTrap column (GE Healthcare) equilibrated with buffer A (20 mM imidazole, 0.3 M NaCl, 50 mM NaH2PO4 pH 7.5) and eluted with a gradient from 0 to 100% buffer B (0.4 M imidazole, 0.3 M NaCl, 50 mM NaH2PO4 pH 7.5). 2 mM 2-mercaptoethanol was added to the eluted protein. Concentrated protein samples were then loaded onto a HiLoad Superdex 200 16/60 column (GE Healthcare) using 0.3 M NaCl, 30 mM HEPES pH 7.5 as running buffer. Proteins were concentrated and frozen in liquid nitrogen. Selenomethionine-labelled wild-type Atg18 was expressed in selenomethionine containing minimal medium[37] and purified with a HisTrap column using buffer A (20 mM imidazole, 500 mM NaCl, 50 mM HEPES pH 7.5) and buffer B (500 mM imidazole, 500 mM NaCl, 50 mM HEPES pH 7.5). In the second purification step, the protein was loaded onto a gel filtration column with a gel filtration buffer consisting of 300 mM NaCl, 30 mM HEPES pH 7.0.
Crystallization and structure determination
Proteinase K was added in a 1:2000 (w/w) ratio to selenomethionine labelled Atg18 before setting-up the crystallization trials. Plate-like crystals grew with 2 µL 30 mg/ml protein and 2 µL 20% (w/V) PEG 8000, 0.2 M NaCl, 0.1 M sodium phosphate dibasic-citric acid pH 4.2 as precipitant (condition 31, Wizard 1 screen, Rigaku) in Linbro plates at 20 °C. Citrate-bound crystals were transferred into mother liquor containing 30% ethylene glycol. Phosphate-bound crystals were gradually transferred into a cryoprotectant consisting of 10% (w/V) xylitol, 10% (w/V) sucrose, 20% PEG 8000, 0.2 M NaCl, 0.4 M sodium dihydrogen phosphate pH 5.0. Crystals were flash-cooled in liquid nitrogen.Diffraction data were collected at 100 K at the SLS beamline X10SA. Diffraction data were processed with the XDS software package[38]. The structure was determined by molecular replacement with K. lactisHsv2 as a search model (PDB: 4AV8, residues 251–278 and 320–327 were deleted). Molecular replacement was done with Phaser-MR within PHENIX[39]. Two molecules were placed in the unit cell with a translation Z-score of 9.8. Automated model building was done with PHENIX. Manual rebuilding was done with COOT[40] and the model was refined with REFMAC5[41] and PHENIX[42].Figures were prepared with PyMOL[43]. Ligand-protein interactions were visualized with LigPlot+[44]. Protein sequences were aligned with ClustalOmega[45] and analyzed with Consurf[46]. P. angustaAtg18, S. cerevisiaeAtg18 (P43601), Komagataella pastoris Atg18 (Q8X1F5), Scheffersomyces stipitis Atg18 (A3GFE3), Debaryomyces hanseniiAtg18 (Q6BIL4), Meyerozyma guilliermondiiAtg18 (A5DHI9), Candida albicansAtg18 (Q5ABA6), Candida glabrataAtg18 (Q6FM63), Aspergillus nigerAtg18 (A2RAG5), Ustilago maydisAtg18 (Q4P4N1), Penicillium chrysogenumAtg18 (A7KAM8), Aspergillus terreusAtg18 (Q0CW30), Aspergillus clavatus Atg18 (A1CBB8), Magnaporthe oryzaeAtg18 (Q524W4), Sclerotinia sclerotiorum Atg18 (A7EW77), Ashbya gossypii Atg18 (Q75F47) and Phaeosphaeria nodorum Atg18 (Q0U2J8) were included in this analysis.
Preparation of large unilamellar vesicles
Lipids were purchased from Avanti Polar Lipids and Texas Red-PE was obtained from Thermo Fisher Scientific. Lipid vesicles were generated by mixing of the different lipidschloroform stock solutions in the desired proportions. Lipids were dried in an oxygen-free nitrogen stream and the last traces of organic solvent were removed under vacuum in a vacuum desiccator for at least 3 h. Dried phospholipids were resuspended in buffer by vigorous vortexing. Large unilamellar vesicles with a diameter of around ~140 nm were prepared by extrusion of the rehydrated phospholipid suspensions with 21 strokes through a 0.1 µm polycarbonate membrane (Millipore Inc., Bedford, MA, USA) with a mini-extruder (Avanti Polar Lipids). Homogeneity of liposome preparations was confirmed by dynamic light scattering measurements with a DynaPro machine (Wyatt Technology).
Liposome flotation assays
A 1 mg lipid mixture composed of DOPC/DOPE/PtdIns(3,5)P2/Texas Red-PE (76:21:1:2, molar ratio) was dried and then dissolved in 700 µL HP150 buffer composed of 150 mM KCl, 20 mM HEPES pH 7.4. LUVs were prepared with the mini-extruder using a 0.1 µm polycarbonate filter as described above. 5 µL 1 µM protein was mixed with 45 µL liposomes and incubated for 10 min at room temperature. 50 µL protein-liposome sample was then thoroughly mixed with 50 µL 80% (w/V) Nycodenz dissolved in HP150 and overlaid with 50 µL 30% (w/V) Nycodenz. 30 µL HP150 was added as top layer[47]. Samples were spun for 90 min at 55000 rpm (275000 × g) at 4 °C in a S55-S swinging bucket rotor in a Sorvall Discovery M150 SE analytical ultracentrifuge (Thermo Scientific). After centrifugation, 30 µL samples were taken from the gradient and analyzed by western blotting. Penta-Hishorseradish peroxidase conjugate antibody (Qiagen) was used in a 1:1500 dilution for detection.
Protein labelling
Texas Red C2 Maleimide (Thermo Fisher Scientific), Oregon Green® 488 Maleimide (Thermo Fisher Scientific), Alexa Fluor 488 C5 Maleimide (Thermo Fisher Scientific), Alexa Fluor 546 C5 Maleimide (Thermo Fisher Scientific) and BADAN (Thermo Fisher Scientific) were used for specific labelling of the cysteine mutants. Proteins were incubated with a fivefold molar excess of the dye while gently shaking overnight at 4 °C. Unreacted dye was removed from the labeled protein with a PD-10 desalting column (GE Healthcare) using HP150 buffer with 0.1 mM TCEP.
Fluorescence based liposome binding assay
LUVs composed of DOPC/DOPE/PtdIns(3,5)P2 (79:20:1, molar ratio) were prepared as described above. BADAN fluorescence emission was measured at 25 °C with a Fluorolog-3 spectrophotometer (Model FL322, HORIBA Jobin Yvon) in the range of 420 nm to 600 nm with an excitation wavelength of 380 nm and 5-nm slit width using 0.25 µM protein and ~500 µM total lipid.Three technical repeats were done for all proteins both in the presence and in the absence of vesicles. Standard deviations (SD) were calculated.We prepared LUVs composed of DOPC/DOPE/Texas Red-PE/PtdIns(3,5)P2 (79:18:2:1, molar ratio) as described above for FRET measurements. Oregon Green fluorescence emission was measured similar to BADAN experiments in the range of 510 nm to 560 nm with an excitation wavelength of 490 nm.
Stopped-flow experiments
Kinetic experiments were carried out with an Applied Photophysics SX.20 stopped-flow spectrophotometer at 25 °C in HP150 buffer with 0.1 mM TCEP as described previously[16]. Alexa Fluor 488 labelled Atg18 (0.5 µM or 0.25 µM) was mixed with equal volumes of increasing concentrations of Texas Red-labelled or Rhodamine B, LUVs (DOPC/DOPE/PtdIns(3,5)P2/labelled-PE (79:18:1:2, molar ratio)), under pseudo-first order conditions. The excitation wavelength was set on 495 nm and a 610 nm cut-off filter was used to collect the Texas Red emission for the different vesicle concentrations tested. The resulting time courses were fit to an exponential function:where F(t) equals the observed fluorescence at time t, F0 is the final fluorescence, Aobs(i) represents the amplitude and k
obs(i) is the observed rate constant for the i th of n phases. Stopped-flow traces were evaluated using a three-exponential fitting, or bi-exponential at low protein concentration condition, yielding up to three k
obs or two k
obs respectively (Supplementary Figure 12). For data analysis, k
obs2 and k
obs3 were discarded due to aggregation during the time course of the measurements.Observed rate constants were plotted as a function of accessible lipid concentration, assuming that only 60% of the total lipid concentration was accessible to the protein, and fitted with the equation:where k
on represents the association constant, and k
off,app the apparent dissociation rate constant.For oligomerization experiments, we performed rapid mixing of acceptor fluorophore labelled Atg18 C113 (0.5 µM), in the presence of LUVs (1 mM total lipid), with (0.5 µM) of acceptor fluorophore labelled Atg18 C113 mutant (0.5 µM) in a 1:1 volume. In order to compare oligomerization with binding and aggregation, unlabelled Atg18 C113 in the presence of Texas red labelled LUVs (1 mM total lipid) were mixed with Oregon Green labelled Atg18 C113. The excitation wavelength was set on 495 nm and a 610 nm cut-off filter for all experiments. Similar conditions were used to monitor the aggregation with unlabelled protein and liposomes at 405 nm. Time courses were normalized for comparison.
Statistical analyses
Statistical analyses were performed with unpaired t tests comparing test samples to wild-type in the same experiment, using the Graphpad QuickCalcs web (http://www.graphpad.com/quickcalcs/).
Chemical cross-linking of Atg18 alone and with LUVs
Either approx. 14 µM or 1.4 µM Atg18 in 200 µL HP150 buffer alone or in the presence of LUVs composed of DOPC/DOPE/PtdIns(3,5)P2 (75:23:2, molar ratio) in 200 µL HP150 buffer were cross-linked with 2 µl 5 mM Bis[sulfosuccinimidyl] suberate (BS3) for 1 hr at 25 °C and 300 rpm. After cross-linking, the protein was precipitated with ethanol.
Sample preparation for MS
The pellet from ethanol precipitation was dried in a vacuum centrifuge and dissolved in 1% (m/v) RapiGest SF Surfactant (Waters) in 25 mM ammonium bicarbonate. Atg18 was reduced with 10 µl 50 mM dithiothreitol for 1 hr at 37 °C and 300 rpm. Reduced cysteine residues were alkylated with 10 µl 100 mM iodoacetamide for 1 hr at 37 °C and 300 rpm. RapiGest was diluted with 25 mM ammonium bicarbonate to 0.1% (m/v) final concentration and Atg18 was digested with trypsin at a 1:20 enzyme: protein concentration ratio overnight at 37 °C. RapiGest was decomposed by addition of 20 µl 5% (v/v) trifluoric acid and incubation at 37 °C and 300 rpm for 2 hrs. RapiGest was removed by centrifugation at 13,000 rpm for 30 mins and the peptides were dried in a vacuum centrifuge.Peptides were re-dissolved in 30% (v/v) acetonitrile, 0.1% (v/v) trifluoric acid. Linear peptides and cross-linked di-peptides were separated by size exclusion chromatography on a Superdex peptide column 10/300 GL (GE healthcare) at a flow rate of 50 µl/min. Fractions containing mostly cross-linked di-peptides were dried in a vacuum centrifuge and re-dissolved in 2% (v/v) acetonitrile, 0.05% (v/v) trifluoric acid.
LC-MS/MS and database search to identify cross-linked peptides
Dissolved peptides were separated by nano-flow reversed-phase liquid chromatography (Dionex UltiMate 3000 RSLC, Thermo Scientific; mobile phase A: 0.1% (v/v) formic acid; mobile phase B: 80% (v/v) acetonitrile, 0.08% (v/v) formic acid). Peptides were loaded onto a trap column (Reprosil C18, 100 μm I.D., particle size 5 μm; Dr. Maisch GmbH, prepared in-house) and separated with a flow rate of 300 nL/min on an analytical C18 capillary column (Reprosil C18, 75 μm I.D., particle size 1.9 μm, 27–28 cm; Dr. Maisch GmbH, prepared in-house), with a gradient of 5–90% (v/v) mobile phase B over 75 min. Separated peptides were directly eluted into an Orbitrap Fusion Tribrid Mass Spectrometer (Thermo scientific).Typical mass spectrometric conditions were: spray voltage of 2.5 kV; capillary temperature of 275 °C; normalized collision energy of 30% at an activation of q = 0.25 and an activation time of 30 ms. The Orbitrap Fusion Tribrid Mass Spectrometer was operated in data-dependent mode. Survey full scan MS spectra were acquired in the orbitrap (m/z 500–1700) with a resolution of 120,000 and an automatic gain control (AGC) target at 500,000. The top 20 most intense ions were selected for HCD MS/MS fragmentation in the orbitrap at an AGC target of 30,000 and with a first m/z of 110. Previously selected ions within previous 30 s were dynamically excluded for 20 s. Ions with charge states 3–8 were selected. Singly and doubly charged ions as well as ions with unrecognized charge state were excluded in order to increase the selection of highly-charged cross-linked peptides. Internal calibration of the orbitrap was performed using the lock mass option (lock mass: m/z 445.120025)[48].Raw data files were converted into mgf format using pXtract software tool (http://pfind.ict.ac.cn/software.html). Potential cross-links were then identified by database searching against a reduced database containing Atg18 using pLink search engine[26]. Search parameters were: fragmentation, HCD; enzyme, Trypsin; variable modifications, oxidation (methionine) and carbamidomethylation (cysteine); cross-linker, BS3. Spectra of potential cross-linked di-peptides were verified manually. Cross-links were visualised using the XV is software tool[49].
Mass spectrometry of intact Atg18 oligomers
The buffer of purified Atg18 was exchanged to 200 mM ammonium acetate using Micro Bio-Spin 6 gel filtration columns (Bio Rad). Intact Atg18 oligomers were then analyzed on a Q-ToF Ultima mass spectrometer modified for transmission of high mass complexes[28] using gold-coated capillaries prepared in-house[50]. Typical mass spectrometric condition were: Capillary voltage, 1.7 kV; Cone voltage, 70 V; RF lens voltage, 180 V; collision energy, 25 V. Mass spectra were processed and analyzed using MassLynx 4.0 software.
CD spectroscopy
CD measurements were performed using a Chirascan spectrometer (Applied Photophysics) for 0.2–0.3 mg/ml protein (monitored using Pierce™ 660 nm Protein Assay, Thermo Fisher Scientific) in 0.15 M NaF, 20 mM NaH2PO4 pH 7.5 (in a 0.1 cm Hellma quartz cuvette) between 190 and 260 nm at 25 °C (using 1 nm step size and 0.5 nm band width). Samples were centrifuged at 14000 rpm before measurements to remove aggregated and precipitated protein.
Data availability
Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes: 5LTD and 5LTG. Other data ara available from the corresponding authors upon reasonable request.
Authors: Hannah C Dooley; Minoo Razi; Hannah E J Polson; Stephen E Girardin; Michael I Wilson; Sharon A Tooze Journal: Mol Cell Date: 2014-06-19 Impact factor: 17.970
Authors: Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read Journal: J Appl Crystallogr Date: 2007-07-13 Impact factor: 3.304
Authors: Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong Journal: Autophagy Date: 2021-02-08 Impact factor: 13.391
Authors: Wen Xiong; Tuo-Xian Tang; Evan Littleton; Arba Karcini; Iulia M Lazar; Daniel G S Capelluto Journal: Sci Rep Date: 2019-07-26 Impact factor: 4.379